A list of fifteen small molecules derived from INSM1-promoter driven luciferase assay is described below in the context of their names, compound nature, and the IC50 viability (against BE2-M17), which could be potentially useful for NB cancer therapy. The gene discussed is INSM1; the disease is neuroblastoma.